David M. Rubenstein's most recent trade in Carlyle Group Inc (The) was a trade of 625,000 Common Stock done at an average price of $56.6 . Disclosure was reported to the exchange on Dec. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Carlyle Grp Inc | David M. Rubenstein | Director | Sale of securities on an exchange or to another person at price $ 56.55 per share. | 10 Dec 2025 | 625,000 | 27,999,644 (8%) | 0% | 56.6 | 35,343,750 | Common Stock |
| Carlyle Grp Inc | David M. Rubenstein | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2025 | 625,000 | 28,624,644 (8%) | 0% | 0 | Common Stock | |
| Moderna | David M. Rubenstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2025 | 850 | 1,527 (0%) | 0% | - | Common Stock | |
| Moderna | David M. Rubenstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2025 | 850 | 0 | - | - | Restricted Stock Units | |
| Moderna | David M. Rubenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 12,756 | 12,756 | - | - | Stock Option (Right to Buy) | |
| Moderna | David M. Rubenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 8,116 | 8,116 | - | - | Restricted Stock Units | |
| Moderna | David M. Rubenstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 677 | 0 | - | - | Restricted Stock Units | |
| Moderna | David M. Rubenstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 677 | 677 (0%) | 0% | - | Common Stock | |
| Moderna | David M. Rubenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 5,051 | 5,051 | - | - | Stock Option (Right to Buy) | |
| Moderna | David M. Rubenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 4,065 | 4,065 | - | - | Stock Option (Right to Buy) | |
| Moderna | David M. Rubenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 850 | 850 | - | - | Restricted Stock Units | |
| Moderna | David M. Rubenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 677 | 677 | - | - | Restricted Stock Units | |
| Carlyle Grp Inc | David M. Rubenstein | Director | Sale of securities on an exchange or to another person at price $ 38.67 per share. | 06 Jun 2022 | 2,000,000 | 29,249,644 (8%) | 0% | 38.7 | 77,340,000 | Common Stock |
| Carlyle Grp Inc | David M. Rubenstein | Director | Sale of securities on an exchange or to another person at price $ 58.00 per share. | 09 Nov 2021 | 2,000,000 | 31,249,644 (8%) | 0% | 58 | 116,000,000 | Common Stock |
| Carlyle Grp Inc | David M. Rubenstein | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 41.76 per share. | 18 May 2021 | 2,000,000 | 37,249,644 (10%) | 0% | 41.8 | 83,520,000 | Common Stock |